EUVIMEDEUVIMED entdecken
Multizentrische Studie

Multicenter Study on the Frequency of Low Bone Mineral Density in Young Women With Breast Cancer and Associated Factors

Fernanda Mesa-Chavez, Yanin Chavarri-Guerra, Adara Valeria López-Covarrubias, Andrea Elena Mayette-Villanueva, Sandy Ruiz-Cruz, Christopher Jesús Del Río-Martínez, Carmen Guadalupe Bermudez-Barrientos, Abigail Samayoa-Mateos, Alejandra Gabriela Manzanares-Castellanos, Brizio Moreno-Jaime, David Vega-Morales, Juan Alberto Tenorio-Torres und 1 weitere

Clinical Breast Cancer · 2024-08 · 24 (6) · 501-509.e2

DOI: 10.1016/j.clbc.2024.04.012 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Breast Cancer, 2024-08. Verfasst von Fernanda Mesa-Chavez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Tecnologico de Monterrey, School of Medicine and Health Sciences, Monterrey, Mexico; Joven & Fuerte: Programa para la Atencion e Investigacion para P…. Hauptthemen laut MEDLINE: Breast Neoplasms, Bone Density, Absorptiometry, Photon. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Young women with breast cancer (BC) may experience bone mineral density (BMD) loss secondary to cancer treatment effects on estrogen levels. Studies assessing BMD in BC patients have had a limited representation of young women. This multicenter retrospective study analyzed the frequency of low BMD and associated factors in this age group. METHODS: Women diagnosed with stage 0-III BC at ≤40 years, treated with chemotherapy and/or endocrine therapy between 2010 and 2020 at 5 Mexican BC referral centers were eligible. Demographic, clinical and treatment data were collected, as well as bone dual-energy X-ray absorptiometry (DEXA) results. Low BMD was defined as lumbar or femoral neck T-score < -1.0 or Z-score ≤ -2.0. RESULTS: A total of 1259 patients were included; median age at diagnosis was 36 years (21-40). Overall, 93% received chemotherapy and 65% endocrine therapy (tamoxifen was received at some point by 61%, aromatase inhibitors by 17%, and GnRH agonists/bilateral oophorectomy by 21%). DEXA scans were documented in 254 (20%), of which 163 (64%; 95% confidence interval [CI] 58%-70%) had a low BMD report. Low BMD was associated with receiving aromatase inhibitors (Odds ratio [OR] 1.92; 95% CI 1.13-3.24), and GnRH agonists/bilateral oophorectomy (OR 2.25; 95% CI 1.21-4.21). CONCLUSION: The suboptimal frequency of BMD monitoring observed displays an alarming disregard for bone health in young patients. Thus, a high proportion of women with low BMD are potentially being missed and precluded from the opportunity to receive timely interventions. Particular focus should be put on BMD monitoring among patients treated with aromatase inhibitors, GnRH agonists or bilateral oophorectomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBone DensityAbsorptiometry, PhotonHumansFemaleAdultRetrospective StudiesYoung AdultAromatase InhibitorsOsteoporosisMexicoAntineoplastic Agents, Hormonal

Stichwörter der Autor:innen

Bone lossLow bone density

Substanzen

Aromatase InhibitorsAntineoplastic Agents, Hormonal

Autor:innen und Institutionen

  • Tecnologico de Monterrey, School of Medicine and Health Sciences, Monterrey, Mexico; Joven & Fuerte: Programa para la Atencion e Investigacion para Pacientes Jovenes con Cancer de Mama en Mexico, Mexico City, Mexico; Br…
  • Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Fundación de Cáncer de Mama (FUCAM), A.C., Mexico City, Mexico.
  • Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, Monterrey, Mexico.
  • Hospital Regional ISSSTE León, Leon, Mexico.

Zitieren

APA

Mesa-Chavez, F., Chavarri-Guerra, Y., López-Covarrubias, A. V., Mayette-Villanueva, A. E., Ruiz-Cruz, S., Del Río-Martínez, C. J., Bermudez-Barrientos, C. G., Samayoa-Mateos, A., Manzanares-Castellanos, A. G., Moreno-Jaime, B., Vega-Morales, D., Tenorio-Torres, J. A., & Villarreal-Garza, C. (2024). Multicenter Study on the Frequency of Low Bone Mineral Density in Young Women With Breast Cancer and Associated Factors. Clinical Breast Cancer, 24(6), 501-509.e2. https://doi.org/10.1016/j.clbc.2024.04.012

Vancouver

Mesa-Chavez F, Chavarri-Guerra Y, López-Covarrubias AV, Mayette-Villanueva AE, Ruiz-Cruz S, Del Río-Martínez CJ, et al. Multicenter Study on the Frequency of Low Bone Mineral Density in Young Women With Breast Cancer and Associated Factors. Clinical Breast Cancer. 2024;24(6):501-509.e2. doi:10.1016/j.clbc.2024.04.012

BibTeX
@article{MesaChavez2024,
  author = {Mesa-Chavez, Fernanda and Chavarri-Guerra, Yanin and López-Covarrubias, Adara Valeria and Mayette-Villanueva, Andrea Elena and Ruiz-Cruz, Sandy and Del Río-Martínez, Christopher Jesús and Bermudez-Barrientos, Carmen Guadalupe and Samayoa-Mateos, Abigail and Manzanares-Castellanos, Alejandra Gabriela and Moreno-Jaime, Brizio and Vega-Morales, David and Tenorio-Torres, Juan Alberto and Villarreal-Garza, Cynthia},
  title = {Multicenter Study on the Frequency of Low Bone Mineral Density in Young Women With Breast Cancer and Associated Factors},
  journal = {Clinical Breast Cancer},
  year = {2024},
  volume = {24},
  number = {6},
  pages = {501--509.e2},
  doi = {10.1016/j.clbc.2024.04.012}
}
Kostenlos starten →